Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial.

about

Optimal timing of initiation of oral P2Y12-receptor antagonist therapy in patients with non-ST elevation acute coronary syndromes. Lessons learnt from the ACCOAST-trial.

Item

http://www.wikidata.org/entity/Q53523898

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@en

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@nl

type

Item

label

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@en

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@nl

prefLabel

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@en

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@nl

P1476

Optimal timing of initiation o ...... learnt from the ACCOAST-trial.

@en

P2093

Diego Ardissino

http://www.w3.org/2001/XMLSchema#string

Jean-Philippe Collet

http://www.w3.org/2001/XMLSchema#string

Jose Lopez-Sendon

http://www.w3.org/2001/XMLSchema#string

Leonardo Bolognese

http://www.w3.org/2001/XMLSchema#string

Peter Clemmensen

http://www.w3.org/2001/XMLSchema#string

Petr Widimsky

http://www.w3.org/2001/XMLSchema#string

Uwe Zeymer

http://www.w3.org/2001/XMLSchema#string

P2860

Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necro

Loading with 600 mg clopidogrel in patients with coronary artery disease with and without chronic clopidogrel therapy

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study.

Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.

P304

282-288

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2048872615584076

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilles Montalescot

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25921481

http://www.w3.org/2001/XMLSchema#string